Clinical Trial Update: Nitrous Oxide Analgesia Vaso-occlusive Crisis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitrous oxide analgesia for vaso-occlusive crisis in sickle cell disease has completed, with results posted on 2024-07-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• Nitrous oxide analgesia (nitrous oxide)

Snippet

Sponsor: Columbia University | Conditions: Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | Status: COMPLETED | Results posted: 2024-07-16